Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:14:51.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record of a Phase II therapeutic trial of pembrolizumab and bavituximab in patients with locally advanced Hepatocellular Carcinoma, focusing on treatment efficacy and safety assessments.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:56.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes a detailed explanation of eligibility criteria, such as a person's general health condition or prior treatments, and provides a link for general information about clinical research.
    Difference
    35%
    Check dated 2024-05-22T20:34:02.000Z thumbnail image
  8. Check
    41 days ago
    Change Detected
    Summary
    The value 'No Posted (Estimated)' on the webpage has recently changed to 'Submitted.' This change likely indicates that the status of a submission related to medical and healthcare publications or documentation has been updated.
    Difference
    0.1%
    Check dated 2024-05-06T17:25:43.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Summary
    The value on the webpage has changed from an estimated study completion date of 2024-01 to an actual study completion date of 2024-05-03. This change likely indicates that the medical and healthcare-related study has progressed and reached its completion milestone.
    Difference
    0.9%
    Check dated 2024-05-04T09:42:15.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:31:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.